发明名称 Herstellung von neuen 7-Methyl-19-nor-androstadienen
摘要 1,158,332. 7&alpha; - Methyl 19 - nor - androstadienes. CIBA Ltd. 25 July, 1966 [30 July, 1965; 10 Sept., 1965; 27 June, 1966], No. 33284/66. Heading C2U. Novel steroids of the formula (wherein R is oxo or free, esterified or etherified #-OH with or without an &alpha;-aliphatic hydrocarbon group of up to 4 carbon atoms which may be substituted) are prepared from the corresponding #<SP>5'10'</SP>-steroids by bromination and dehydrobromination. In the products, a 17#-OH group may be esterified or etherified, or an esterified or etherified 17#-OH group hydrolysed; or a 17-oxo group may, after protection of the 3-oxo group, be converted to a 17&alpha;- hydrocarbyl-17#-OH grouping and the 3-keto group then liberated. The #<SP>5'10'</SP>-steroid starting materials may also be converted to the required products by microbiological 11 -hydroxylation, dehydration to the corresponding #<SP>5'01'</SP> <SP>9'11'</SP>-steroids and treatment of these with a mineral acid, or by conversion of the 11- hydroxy compounds to sulphonic acid esters thereof, and then treatment with an alkali metal salt of a lower aliphatic carboxylic acid. #<SP>4</SP> <SP>9</SP> - 7&alpha; methyl - 3 - oximino 17 - oxo - 19- nor-androstadiene is prepared by reacting 3,17- dioxo-7&alpha;-methyl-#<SP>4</SP> <SP>9</SP>-19-nor-androstadiene with HCN or a derivative thereof to convert the 17- oxo group to a cyanohydrin group, reacting the #<SP>4</SP> <SP>9</SP> - 7&alpha; - methyl - 3 - oxo - 17 - cyano - 17#- hydroxy-19-nor-androstadiene with hydroxylamine or a lower alkyl hydroxylamine to give #<SP>4</SP> 9 - 7&alpha; - methyl - 3 - oximino - 17 - cyano - 17#- hydroxy-19-nor-androstadiene and then saponifying this. 3 - Oxo - 7a - methyl - 17# - hydroxy - #<SP>5'10'</SP>- 19-nor-androstene is prepared by hydrolysis of 3 - methoxy - 7&alpha; - methyl - 17# - hydroxy - #<SP>2</SP> <SP>5'10'</SP>- 19 - nor - androstadiene, prepared in turn by LiAlH 4 reduction of 7&alpha;-methyl-estrone methyl ether, to give 3-methoxy-7&alpha;-methyl- 17#-hydroxy- #<SP>1</SP> <SP>3</SP> <SP>5'10'</SP>-estratriene, and Birch reduction of this. 3 - Oxo - 7&alpha;,17&alpha; - dimethyl - 17# - hydroxy - #<SP>5'10'</SP>- 19-nor-androsfene is prepared by hydrolysis of 3 - methoxy - 7&alpha;,17&alpha; - dimethyl - 17# - hydroxy- #<SP>2</SP> <SP>5'10'</SP>-19-nor-androstadiene, itself prepared from the 17-ketone. The corresponding 17&alpha;-ethynyl compounds are prepared similarly. 3 - Methoxy - 7&alpha; - methyl - 11 - hydroxy - 17- ethylenedioxy - #<SP>2</SP> <SP>5'10'</SP> - 19 - nor - androstadiene is prepared by ketalizing 3-methoxy-7&alpha;-methyl- 17 - oxo - #<SP>1</SP> <SP>3</SP> <SP>5'10'</SP> <SP>9'11'</SP> - 19 - nor - androstatetraene (prepared by methylation of the 3-ol) to give the corresponding 17-ketal, reacting this with mchloro-perbenzoic acid to give 3-methoxy-7&alpha;- methyl - 9,11 - oxido - 17 - ethylenedioxy- #<SP>1</SP> <SP>3</SP> <SP>5'10'</SP>-19-nor-androstratiene, and reducing this with sodium in liquid ammonia; and is converted to the 17-ketone of the invention by dehydration with POCl 3 and hydrolysis with HCI. The 7&alpha;-methyl-steroids of the invention, which are stated to possess androgenic, anabolic, antigonadotrophic and gestagenic action, may be made up into pharmaceutical and veterinary compositions with suitable carriers.
申请公布号 DE1568306(A1) 申请公布日期 1970.03.12
申请号 DE19661568306 申请日期 1966.07.21
申请人 CIBA AG 发明人 ANNER,DR.GEORG;WIELAND,DR.PETER
分类号 C07J1/00;C07J75/00 主分类号 C07J1/00
代理机构 代理人
主权项
地址